Global Cell Lysis & Disruption Market expected to grow to USD 11.15 billion by 2033

From GlobeNewswire: 2024-05-20 07:00:00

The Global Cell Lysis & Disruption Market is expected to grow from USD 4.95 billion in 2023 to USD 11.15 billion by 2033, with a CAGR of 8.46%. Cell lysis releases biological materials, and applications include protein purification, DNA isolation, drug screening, and more. Factors driving market growth include advancements in genomics research and precision medicine. The reagent-based segment is projected to hold the largest market share, offering cost-effective solutions without expensive equipment. The mammalian cell segment dominates the market, particularly in protein isolation applications. The pharmaceutical and biotechnology companies segment leads in revenue share, driving adoption of improved cell lysis technologies for drug development. North America dominates the market, fueled by advancements in biopharmaceuticals and life sciences. The Asia-Pacific region is expected to grow fastest, with a focus on technological advancements in personalized cancer medicine. Major vendors in the market include Thermo Fisher Scientific, Merck KGaA, and Danaher, among others. In July 2023, Qiagen launched a new digital PCR kit for cell and gene therapy applications. The market is segmented by technique, product, cell type, application, end-use, and region. Forecasts predict revenue growth at the global, regional, and country levels.



Read more at GlobeNewswire: Global Cell Lysis and Disruption Market Size to Exceed USD